SAM
KITE

Sectoral Asset Management’s Kite Pharma, Inc. KITE Stock Holding History

Sectoral Asset Management’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-63,520
Closed -$4.99M – 72
2017
Q1 		$4.99M Sell
63,520
-308,703
-83% -$19.1M 0.58% 37
2016
Q4 		$16.7M Buy
372,223
+255,897
+220% +$12.6M 1.85% 22
2016
Q3 		$6.5M Buy
+116,326
New +$6.48M 0.64% 37

Other funds holding KITE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
WCM
Wildcat Capital Management New York $106M AUM 0.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Sectoral Asset Management's KITE Position: Q2 2017 in Review

Sectoral Asset Management sold out of Kite Pharma, Inc. (KITE) in Q2 2017, closing a stake of 63,520 shares — an estimated $4.99M sold.

Sectoral Asset Management first reported a position in KITE in Q3 2016 and held it in 3 quarters. The position peaked at $16.7M in Q4 2016. 220 funds tracked by Wall St. Rank hold KITE as of Q2 2017.

  • Sectoral Asset Management reported no remaining Kite Pharma, Inc. position as of Q2 2017 after selling out during the quarter.
  • Sectoral Asset Management sold 63,520 Kite Pharma, Inc. shares in Q2 2017, an estimated $4.99M.
  • Sectoral Asset Management first reported a position in Kite Pharma, Inc. in Q3 2016 and held it in 3 quarters.
  • Sectoral Asset Management's Kite Pharma, Inc. position peaked at $16.7M in Q4 2016.
  • 220 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q2 2017.

Based on Sectoral Asset Management's 13F filing for Q2 2017, filed 14 Aug 2017.